Tigecycline failed to reach 'non-inferiority' in the clinical evaluable population, which was the primary objective in that study; cure rates were 67.9% for tigecycline and 78.2% for imipenem ...

Cephalosporin, imipenem or other allergy: not recommended. Discontinue if allergic reaction or drug-induced enterocolitis syndrome occurs. Avoid in those with mononucleosis. Evaluate if diarrhea ...

We also suggest that the category of ESBLs should be expanded. However, we recently found that the CMY-10 ESBL had higher imipenem-hydrolysing activity than OXA-23, a class D carbapenemase 7,10.

Cephalosporin, imipenem or other allergy: not recommended. Discontinue if allergic reaction or drug-induced enterocolitis syndrome occurs. Avoid in those with mononucleosis. Evaluate if diarrhea ...

Furthermore, meropenem is administered less frequently than imipenem-cilastatin and may be associated with a lower frequency of gastrointestinal adverse effects. [1] Generally, carbapenems have ...

Similarly, Klebsiella pneumoniae and Pseudomonas aeruginosa also demonstrated rising resistance, particularly to important antibiotics like piperacillin-tazobactam, imipenem, and meropenem.

Similarly, Klebsiella pneumoniae and Pseudomonas aeruginosa, two other important bacteria, also showed increasing resistance ...

New Data to be Presented at IDWeek 2024 Reinforce Merck’s Broad and Diverse Vaccines and Infectious Disease Pipeline and ...

Similarly, Klebsiella pneumoniae and Pseudomonas aeruginosa also showed increasing resistance, especially to critical antibiotics like piperacillin-tazobactam, imipenem, and meropenem.